In previous epidemiological prospective cohort surveys [3]–[5], elevated ALT activity was associated with all-cause/cause specific (including cardiovascular (CV) disease, cancer, and liver disease) mortality in long-term follow-up duration. This evidence concerns the gene GPT and liver disorder.